Techne Corporation Declares Dividend

MINNEAPOLIS, May 3, 2011 /PRNewswire/ -- Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.27 per share for the quarter ended March 31, 2011.  The quarterly dividend will be payable May 27, 2011 to all common shareholders of record on May 13, 2011.  Future cash dividends will be considered by the Board of Directors on a quarterly basis.

Techne Corporation has two operating subsidiaries:  Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota, and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England.  R&D Systems is a specialty manufacturer of biological products.  R&D Systems has three subsidiaries, BiosPacific, Inc. (BiosPacific), located in Emeryville, California, Boston Biochem, Inc. (Boston Biochem) located in Cambridge, Massachusetts, and R&D Systems China Co. Ltd., (R&D China), located in Shanghai, China.  BiosPacific is a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems and immunodiagnostic kits.  Boston Biochem is a leading developer of ubiquitin-related research products.  R&D China and R&D Europe distribute biotechnology products.

SOURCE Techne Corporation

Suggested Articles

CureVac named a permanent CEO, Franz-Werner Haas, and signed Novartis alum, Igor Splawski, Ph.D. as its new top scientist.

J&J studied the drug in midphase obesity clinical trials, but Merck sees it as a potential treatment for nonalcoholic steatohepatitis.

The Big Pharma paid $134 million to enter into the two partnerships but then dropped the projects after Voyager completed research activities.